[Comparative assessment of molecular abberation in medulloblastomas].
Medulloblastoma is a heterogeneous disease with molecular variants and distinct biological behavior. Studying molecular abnormalities in medulloblastomas will allow to stratify patients into key populations and optimize aduvant therapy reducing long-term adverse effects.